[Federal Register Volume 89, Number 84 (Tuesday, April 30, 2024)]
[Notices]
[Pages 34259-34260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09303]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary, Muscular Dystrophy Coordinating 
Committee Call for Committee Membership Nominations

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Office of the Secretary of the Department of Health and 
Human Services (HHS) is seeking nominations for one individual to serve 
as a non-Federal public member on the Muscular Dystrophy Coordinating 
Committee.

DATES: Nominations are due by 5:00 p.m. ET on May 31, 2024.

ADDRESSES: Nominations must be sent to Glen Nuckolls, Ph.D., by email 
to [email protected].

FOR FURTHER INFORMATION CONTACT: Glen Nuckolls, Ph.D., by email to 
[email protected] or (301) 496-5745.

SUPPLEMENTARY INFORMATION: The Muscular Dystrophy Coordinating 
Committee (MDCC) is a Federal advisory committee established in 
accordance with the Muscular Dystrophy Community Assistance, Research, 
and Education Amendments of 2001 (MD-CARE Act; Pub. L. 107-84). The MD-
CARE Act was reauthorized in 2008 by Public Law 110-361, and again in 
2014 by Public Law 113-166. The MD-CARE Act specifies that the 
committee membership be composed of \2/3\ governmental agency 
representatives and \1/3\ public members. We are seeking nominations 
for one non-Federal public member at this time, due to turnover of 
committee membership. Nominations will be accepted until 5:00 p.m. ET 
on May 31, 2024.

[[Page 34260]]

    Who is Eligible: Nominations are encouraged for new or 
reappointment of non-Federal public members who can provide the public 
and/or patient perspectives to discussions of issues considered by the 
Committee. Self-nominations and nominations of other individuals are 
both permitted. Only one nomination per individual is required. 
Multiple nominations for the same individual will not increase 
likelihood of selection. Non-Federal public members may be selected 
from the pool of submitted nominations or other sources as needed to 
meet statutory requirements and to form a balanced committee that 
represents the diversity within the muscular dystrophy communities. 
Nominations are especially encouraged from leaders or representatives 
of muscular dystrophy research, advocacy, or service organizations, as 
well as individuals with muscular dystrophy or their parents or 
guardians. In accordance with White House Office of Management and 
Budget guidelines (FR Doc. 2014-19140), federally-registered lobbyists 
are not eligible.
    Committee Composition: The Department strives to ensure that the 
membership of HHS Federal advisory committees is fairly balanced in 
terms of points of view represented and the committee's function. Every 
effort is made to ensure that the views of all genders, all ethnic and 
racial groups, and people with disabilities are represented on HHS 
Federal advisory committees and, therefore, the Department encourages 
nominations of qualified candidates from these groups. The Department 
also encourages geographic diversity in the composition of the 
Committee. Appointment to this Committee shall be made without 
discrimination on the basis of age, race, ethnicity, gender, sexual 
orientation, disability, and cultural, religious, or socioeconomic 
status. Requests for reasonable accommodation to enable participation 
on the Committee should be indicated in the nomination submission.
    Member Terms: Non-Federal public members of the Committee serve for 
a term of three years and may serve for an unlimited number of terms if 
reappointed. Members may serve after the expiration of their terms, 
until their successors have taken office.
    Meetings and Travel: As specified by Public Law 113-166, the MDCC 
``shall meet no fewer than two times per calendar year.'' Travel 
expenses are provided for non-Federal public Committee members to 
facilitate attendance at in-person meetings. Members are expected to 
make every effort to attend all full committee meetings, twice per 
year, either in person or via remote access. Participation in relevant 
subcommittee, working and planning group meetings, and workshops, is 
also encouraged.
    Submission Instructions and Deadline: Nominations are due by 5:00 
p.m. ET on May 31, 2024, and should be sent to Glen Nuckolls, Ph.D., by 
email to [email protected]. Nominations must include contact 
information for the nominee, a current curriculum vitae or resume of 
the nominee, and a paragraph describing the qualifications of the 
person to represent some portion(s) of the muscular dystrophy research, 
advocacy, and/or patient care communities.
    More information about the MDCC is available at https://mdcc.nih.gov/.

    Dated: April 24, 2024.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke, 
National Institutes of Health.
[FR Doc. 2024-09303 Filed 4-29-24; 8:45 am]
BILLING CODE 4140-01-P